australia's next csl?, page-5

Thank you for the kind comments!

"In answer to Mattkid76: The recent TIS Prospectus page 3 refers to the healing rate of 25-50% following up to 20 weeks of treatment. The patients in the first trial were particularly difficult candidates, and it is reasonable to target a >50% healing rate using a normal population and allowing for longer healing periods.

In answer to Roy2U: I think TIS is below everyone's radar until they get their partnership deal in place. That will be the circuit-breaker which propels TIS into much broader broker and investor awareness.

In response to Supertramp: I think it's safer to not expect too much until September/October. Even if the trials finish in June, they need to be analysed and reported on. This could take a month or two. Also, TIS has no urgency for a deal until about October, as it could still meet its milestones if the deal is delayed until then."

Ash81